apoBank swallows bitter Eu500m pill
Deutsche Apotheker- und Ärztebank (apoBank) failed to reach its stated ambition yesterday (Tuesday), when it was forced to price a sub-benchmark sized deal despite targeting a jumbo debut. Market participants were split on whether this and other recent struggles have been caused by bad luck or bad advice.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: